Stockreport

Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Astellas Pharma has entered into a license agreement with Sangamo Therapeutics to use Sangamo's proprietary adeno-associated virus (AAV) capsid, STAC-BBB, to deliver ge [Read more]